Skip to main content
. 2021 Dec 17;5(24):5536–5545. doi: 10.1182/bloodadvances.2021005566

Figure 3.

Figure 3.

Outcomes after venetoclax plus FluBu2 allo-HCT. Kaplan-Meier estimate and log-rank test of probability of OS (blue) and PFS (red) (A) and probability of NRM (blue) and relapse (red) (B). 95% CIs are reported for each outcome. Probability of OS (C) and PFS (D) in relation to ECOG PS of 0 to 1 (blue) vs ECOG PS of 2 (red).